←
high5md510 posts
high5md avatar✓

high5md ✓

@high5md

Concise and in-depth coverage of the most important conferences in the field of oncology and immunology on high5oncology.tv & high5immunology.tv

◷ Joined July 2021▧ 353 Photos and videos
high5md avatar
high5md@high5md·Oct 23

🎥 UEG Week 2026: Outstanding Science & Expert Insights Axel Dignaß, MD, (@DignassAxel) reflects on one of the most exciting meetings in recent years, featuring groundbreaking IBD data, key scientific highlights, and insightful discussions with leading experts in the field. Want to dive deeper into the latest developments? Watch expert discussions and spotlight sessions on high5immunology.TV! 👉 Discover the highlights: high5immunology.tv/ibd/ueg-w… #UEGWeek2026 #UEGWeek #IBD #Gastroenterology #ExpertInsights #ClinicalResearch #MedicalEducation #high5immunologyTV

0:37
high5md avatar
high5md@high5md·Oct 22

🎥 UEG Week 2026 | Crohn’s Disease & IBD Peter Irving, MD, invites you to discover the latest insights on Crohn’s disease and inflammatory bowel disease (IBD) from UEG Week 2026. Explore key study results and expert perspectives on high5immunology.TV! 👉 Discover the highlights: high5immunology.tv/ibd/ueg-w… #UEGWeek2026 #UEGWeek #CrohnsDisease #IBD #Gastroenterology #MedicalEducation #high5immunologyTV

0:19
high5md avatar
high5md@high5md·Oct 22

🎥 Missed UEG Week 2026? No problem! With high5immunology.TV, you can catch up on the key highlights from this year's congress – concise, scientifically sound, and relevant to clinical practice. Explore the latest clinical trial data, key abstracts, and expert perspectives on developments in gastroenterology and digestive health, including inflammatory bowel disease, liver diseases, and other important areas of gastroenterology. Our experts bring together the most relevant congress insights to help you stay up to date with the latest research and clinical developments. 👉 Explore the highlights: high5immunology.tv/ibd/ueg-w… #UEGWeek2026 #UEGWeek #IBD #Gastroenterology #DigestiveHealth #IBD #InflammatoryBowelDisease #Hepatology #ClinicalTrials #MedicalEducation #high5immunologyTV

Post attachment
high5md avatar
high5md@high5md·Oct 21

🎥 UEG Week 2026: A Great Success! Silvio Danese, MD, PhD, (@silvio_silvio75 ) looks back on a successful UEG Week 2026, bringing together more than 14,000 gastroenterologists and showcasing cutting-edge science and the latest data in inflammatory bowel disease (IBD). Discover more insights and scientific highlights from the congress on high5immunology.TV! 👉 Explore the highlights: high5immunology.tv/ibd/ueg-w… #UEGWeek2026 #UEGWeek #IBD #Gastroenterology #ClinicalResearch #MedicalEducation #high5immunologyTV

0:18
high5md avatar
high5md@high5md·Oct 20

🎥 Welcome to UEG Week 2026! In this special message, Alexander Moschen, MD, invites you to explore the latest scientific highlights from this year's congress on high5immunology.TV. From key study results to expert analyses and congress abstracts, our platform brings together important developments in gastroenterology and digestive health – presented by leading international experts. Discover the latest insights from UEG Week 2026, with expert perspectives designed to support clinical practice. 👉 Explore the highlights: high5immunology.tv/ibd/ueg-w… #UEGWeek2026 #UEGWeek #Gastroenterology #DigestiveHealth #ClinicalResearch #ClinicalTrials #MedicalEducation #high5immunologyTV

0:34
high5md avatar
high5md@high5md·Oct 20

🎥 Welcome to UEG Week 2026! The latest scientific highlights from this year's congress are now available on high5immunology.TV. Explore key study results, relevant congress abstracts, and expert perspectives on the latest developments in gastroenterology and digestive health – presented by leading international experts. Discover the most important insights from UEG Week 2026 and stay up to date with the latest developments in clinical research and practice. 👉 Explore the highlights: high5immunology.tv/ibd/ueg-w… #UEGWeek2026 #UEGWeek #IBD #Gastroenterology #DigestiveHealth #ClinicalResearch #ClinicalTrials #MedicalEducation #high5immunologyTV

Post attachment
high5md avatar
high5md@high5md·Oct 19

🎥 Behind the Scenes | UEG Week 2026 A little behind-the-scenes look at our work here at UEG Week in Barcelona! 🇪🇸 Together with leading experts, we're bringing you the latest congress insights and key scientific updates on Crohn’s disease (CD), inflammatory bowel disease (IBD) and ulcerative colitis (UC). ✨ The wait is almost over! Starting tomorrow, October 20, you can explore the latest findings and expert insights on high5immunology.TV. 👉 Stay tuned: high5immunology.tv/ #UEGWeek2026 #UEGWeek #BehindTheScenes #CrohnsDisease #IBD #UlcerativeColitis #Gastroenterology #high5immunologyTV

Post attachmentPost attachmentPost attachment
high5md avatar
high5md@high5md·Oct 19

🎥 Behind the Scenes | UEG Week 2026 Barcelona became the meeting point for the gastroenterology community this weekend – and we're here on site! 🇪🇸 Our team is capturing exciting insights and the latest congress highlights for you. Look forward to reports from our experts, coming your way on October 20 on high5immunology.TV. 📍 Reporting live from Barcelona – stay tuned! #UEGWeek2026 #UEGWeek #Gastroenterology #MedicalEducation #BehindTheScenes #high5immunologyTV

0:13
high5md avatar
high5md@high5md·Jun 12

🎥 Missed EULAR 2026? No problem! With high5immunology.TV, you can catch up on the most important congress highlights – concise, scientifically sound, and highly relevant for clinical practice. Explore the latest clinical trial data, key abstracts, and expert perspectives on rheumatoid arthritis, lupus, psoriatic arthritis, spondyloarthritis, and other immune-mediated diseases. Our international experts attended the congress in London and provide clear, practical insights into the most relevant developments in rheumatology and immunology. ▶️ Watch now, free of charge, on high5immunology.TV – exclusively for healthcare professionals. high5immunology.tv/rheumatol… #EULAR2026 #EULAR #Rheumatology #Immunology #AutoimmuneDiseases #ClinicalTrials #Lupus #JAKInhibitors #PrecisionMedicine #MedicalEducation #ImmunologyResearch #high5immunologyTV

Post attachment
high5md avatar
high5md@high5md·Jun 6

🎥 Welcome to EULAR 2026 In this special message, @XBaraliakos Xenofon Baraliakos, MD, President of EULAR, invites you to explore the latest scientific highlights from this year's congress on high5immunology.TV. From key study results to expert analyses and congress abstracts, our platform brings together the most relevant developments in rheumatology and immunology – presented by leading international experts. The EULAR 2026 content is now available free of charge for healthcare professionals on high5immunology.TV. 👉 Watch now: high5immunology.tv/rheumatol… #EULAR2026 #EULAR #XenofonBaraliakos #Rheumatology #Immunology #AutoimmuneDiseases #ClinicalTrials #MedicalEducation #high5immunologyTV

0:21
high5md avatar
high5md@high5md·Jun 5

🎥 Behind the scenes at EULAR 2026 in London! While the latest breakthroughs in rheumatology and immunology are being presented at the congress, our team is already hard at work behind the camera. Together with leading international experts, we are presenting the most exciting study results, key congress highlights, and their relevance for clinical practice. Stay tuned for concise congress summaries, expert perspectives, and the most important take-home messages from EULAR 2026. 📅 Available June 6th 2026, free of charge, on high5immunology.TV – exclusively for healthcare professionals. #EULAR2026 #EULAR #Rheumatology #Immunology #AutoimmuneDiseases #ClinicalTrials #PrecisionMedicine #MedicalEducation #ImmunologyResearch #high5immunologyTV

Post attachmentPost attachment
OncoAlert avatar
⟳ high5md retweeted
OncoAlert@OncoAlert·May 26

The OncoAlert🚨 Lung faculty’s TOP 10 abstracts In Thoracic🫁 Oncology for #ASCO26 are here — selected by our leads and finalized through a Delphi voting process with our senior #LungCancer experts across #NSCLC & #SCLC . A snapshot of what will shape LUNG oncology at #ASCO26 👇 🔹 HARMONI-6 — Ivonescimab + chemo vs tislelizumab + chemo in sqNSCLC (OS, Ph3) 🔹 LIBRETTO-432 — Adjuvant selpercatinib in RET+ NSCLC (EFS, Ph3) 🔹 WU-KONG28 — Sunvozertinib vs chemo in EGFR Ex20ins NSCLC (Ph3) 🔹 OPTITROP-LUNGO5 — Sac-TMT + pembrolizumab in PD-L1+ NSCLC (Ph3) 🔹 TRITON — Tremelimumab/durvalumab/chemo in STK11/KEAP1/KRAS-mut NSCLC 🔹 CROWN 7-year update — Lorlatinib vs crizotinib in ALK+ NSCLC 🔹 LORIN — Neoadjuvant lorlatinib in stage III ALK+ NSCLC 🔹 ACCELERET-LUNG — 1L pralsetinib in RET+ NSCLC 🔹 Silevertinib (BDTX-1535) — Non-classical EGFR-mut NSCLC 🔹 Concurrent CRT + durvalumab in ES-SCLC (Phase III) Leads @HHorinouchi @UOzkerim @WeOncologists Senior Faculty @GlopesMd @StephenVLiu @peters_solange @CharuAggarwalMD @MartinReck2 @christine_lovly Participating AF @DrMirallas Pinging faculty @bmassutis @UmbertoMalapel1 @jillfeldman4 @bensolomon1 @VanitaNoronha @DrSanjayPopat @DrJNaidoo @Latinamd @JulienMazieres @TerriConneran @BRicciutiMD

Post attachment